Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Reply to m. Koehler et Al.

Efficace F, Cottone F, Lo-Coco F.

J Clin Oncol. 2015 Mar 20;33(9):1091-2. doi: 10.1200/JCO.2014.60.3597. Epub 2015 Feb 17. No abstract available.

PMID:
25691680
2.

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes.

Efficace F, Gaidano G, Breccia M, Criscuolo M, Cottone F, Caocci G, Bowen D, Lübbert M, Angelucci E, Stauder R, Selleslag D, Platzbecker U, Sanpaolo G, Jonasova A, Buccisano F, Specchia G, Palumbo GA, Niscola P, Wan C, Zhang H, Fenu S, Klimek V, Beyne-Rauzy O, Nguyen K, Mandelli F.

Br J Haematol. 2015 Feb;168(3):361-70. doi: 10.1111/bjh.13138. Epub 2014 Oct 1.

PMID:
25272332
3.

Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes.

Efficace F, Mandelli F, Avvisati G, Cottone F, Ferrara F, Di Bona E, Specchia G, Breccia M, Levis A, Sica S, Finizio O, Kropp MG, Fioritoni G, Cerqui E, Vignetti M, Amadori S, Schlenk RF, Platzbecker U, Lo-Coco F.

J Clin Oncol. 2014 Oct 20;32(30):3406-12. doi: 10.1200/JCO.2014.55.3453. Epub 2014 Sep 22.

PMID:
25245446
4.

Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy.

Efficace F, Santini V, La Nasa G, Cottone F, Finelli C, Borin L, Quaresmini G, Di Tucci AA, Volpe A, Cilloni D, Quarta G, Sanpaolo G, Rivellini F, Salvi F, Molteni A, Voso MT, Alimena G, Fenu S, Mandelli F, Angelucci E.

BMJ Support Palliat Care. 2014 Sep 9. pii: bmjspcare-2014-000726. doi: 10.1136/bmjspcare-2014-000726. [Epub ahead of print]

PMID:
25204541
5.

Quality of care in the oncology outpatient setting from patients' perspective: a systematic review of questionnaires' content and psychometric performance.

Brédart A, Kop JL, Efficace F, Beaudeau A, Brito T, Dolbeault S, Aaronson N; EORTC Quality of Life Group.

Psychooncology. 2015 Apr;24(4):382-94. doi: 10.1002/pon.3661. Epub 2014 Sep 5.

PMID:
25196048
6.

Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients.

Pisu S, Caocci G, d'Aloja E, Efficace F, Vacca A, Piras E, Orofino MG, Addari C, Pintor M, Demontis R, Demuru F, Pittau MR, Collins GS, La Nasa G.

Philos Ethics Humanit Med. 2014 Aug 12;9:13. doi: 10.1186/1747-5341-9-13.

7.

The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review.

Dirven L, Taphoorn MJ, Reijneveld JC, Blazeby J, Jacobs M, Pusic A, La Sala E, Stupp R, Fayers P, Efficace F; EORTC Quality of Life Group (Patient Reported Outcome Measurements Over Time In ONcology-PROMOTION Registry).

Eur J Cancer. 2014 Sep;50(14):2432-48. doi: 10.1016/j.ejca.2014.06.016. Epub 2014 Jul 14. Review.

PMID:
25034656
8.

Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid.

Breccia M, Molica M, Efficace F, Minotti C, Latagliata R, Foà R, Lo Coco F.

Br J Haematol. 2014 Nov;167(3):428-30. doi: 10.1111/bjh.12995. Epub 2014 Jun 24. No abstract available.

PMID:
24957334
9.

Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry.

Efficace F, Rees J, Fayers P, Pusic A, Taphoorn M, Greimel E, Reijneveld J, Whale K, Blazeby J; European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Group.

Health Qual Life Outcomes. 2014 Jun 6;12:86. doi: 10.1186/1477-7525-12-86.

10.

Patient-reported outcomes in randomised controlled trials of gynaecological cancers: investigating methodological quality and impact on clinical decision-making.

Efficace F, Jacobs M, Pusic A, Greimel E, Piciocchi A, Kieffer JM, Gilbert A, Fayers P, Blazeby J; EORTC Quality of Life Group Patient Reported Outcome Measurements Over Time In ONcology-PROMOTION Registry.

Eur J Cancer. 2014 Jul;50(11):1925-41. doi: 10.1016/j.ejca.2014.04.005. Epub 2014 May 10. Review.

PMID:
24825114
11.

Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities.

van Leeuwen M, Efficace F, Fosså SD, Bolla M, De Giorgi U, de Wit R, Holzner B, van de Poll-Franse LV, van Poppel H, White J, Collette L, Osanto S, Aaronson NK; European Organisation for Research and Treatment of Cancer Quality of Life Group; Genito-Urinary Cancers Group; Radiation Oncology Group.

Eur J Cancer. 2014 Jul;50(11):1957-63. doi: 10.1016/j.ejca.2014.04.018. Epub 2014 May 9.

PMID:
24820932
12.

Patient-reported outcomes in acute leukemia: a roadmap for future research.

Efficace F, Breccia M, Lo Coco F.

Eur J Haematol. 2014 Jul;93(1):86-7. doi: 10.1111/ejh.12337. Epub 2014 Apr 26. No abstract available.

PMID:
24702186
13.

Moving towards patient-centered decision-making in chronic myeloid leukemia: assessment of quality of life and symptom burden.

Baccarani M, Efficace F, Rosti G.

Haematologica. 2014 Feb;99(2):205-8. doi: 10.3324/haematol.2013.094045. Review. No abstract available.

14.

Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours on behalf of the EORTC Quality of Life Group.

Sodergren SC, White A, Efficace F, Sprangers M, Fitzsimmons D, Bottomley A, Johnson CD.

Crit Rev Oncol Hematol. 2014 Jul;91(1):35-46. doi: 10.1016/j.critrevonc.2014.01.002. Epub 2014 Jan 17. Review.

PMID:
24495942
15.

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes.

Efficace F, Gaidano G, Sprangers M, Cottone F, Breccia M, Voso MT, Caocci G, Stauder R, Di Tucci AA, Sanpaolo G, Selleslag D, Angelucci E, Platzbecker U, Mandelli F.

Ann Oncol. 2014 Feb;25(2):447-54. doi: 10.1093/annonc/mdt557.

16.

Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life.

Abel GA, Klaassen R, Lee SJ, Young NL, Cannella L, Steensma DP, Efficace F.

Blood. 2014 Jan 16;123(3):451-2. doi: 10.1182/blood-2013-11-540021. No abstract available.

17.

The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative.

Alonso J, Bartlett SJ, Rose M, Aaronson NK, Chaplin JE, Efficace F, Leplège A, Lu A, Tulsky DS, Raat H, Ravens-Sieberer U, Revicki D, Terwee CB, Valderas JM, Cella D, Forrest CB; PROMIS International Group.

Health Qual Life Outcomes. 2013 Dec 20;11:210. doi: 10.1186/1477-7525-11-210.

18.

Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia.

Efficace F, Rosti G, Aaronson N, Cottone F, Angelucci E, Molica S, Vignetti M, Mandelli F, Baccarani M.

Haematologica. 2014 Apr;99(4):788-93. doi: 10.3324/haematol.2013.093724. Epub 2013 Nov 15.

19.

Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making.

Efficace F, Feuerstein M, Fayers P, Cafaro V, Eastham J, Pusic A, Blazeby J; EORTC Quality of Life Group (Patient Reported Outcome Measurements Over Time In ONcology-PROMOTION Project).

Eur Urol. 2014 Sep;66(3):416-27. doi: 10.1016/j.eururo.2013.10.017. Epub 2013 Oct 30.

20.

The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice.

Calvert M, Brundage M, Jacobsen PB, Schünemann HJ, Efficace F.

Health Qual Life Outcomes. 2013 Oct 29;11:184. doi: 10.1186/1477-7525-11-184.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk